Aberdeen Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.81M | Buy |
443,319
+130,294
| +42% | +$1.71M | 0.01% | 684 |
|
|
2025
Q1 | $6.89M | Buy |
313,025
+134,982
| +76% | +$2.97M | 0.01% | 641 |
|
|
2024
Q4 | $4.75M | Sell |
178,043
-78,602
| -31% | -$2.1M | 0.01% | 656 |
|
|
2024
Q3 | $6.85M | Buy |
+256,645
| New | +$6.85M | 0.01% | 596 |
|
|
2024
Q1 | – | Sell |
-150,418
| Closed | -$1.65M | – | 957 |
|
|
2023
Q4 | $1.65M | Buy |
+150,418
| New | +$1.65M | ﹤0.01% | 788 |
|